
|Articles|September 7, 2022
Supplements and Featured Publications
- Diagnosis and Trial Options in Sarcoma
- Volume 1
- Issue 1
Exploring the Interaction of MDM2 and p53 in Soft Tissue Sarcomas
Advertisement
Articles in this issue
over 3 years ago
Dr. Blay on Treatment Considerations in Soft Tissue Sarcomasover 3 years ago
Dr. LoRusso on the Benefit of Genetic Sequencing in Sarcomasover 3 years ago
Dr. Martin-Broto on MDM2 and P53 in Soft Tissue Sarcomaover 3 years ago
Dr. LoRusso on the Efficacy of BI 907828 in Solid TumorsAdvertisement
Latest CME
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma
2
NP-G1-044 Receives FDA Orphan Drug Designation for Pancreatic Cancer
3
Ixazomib-Based Regimens Expand Options in Relapsed/Refractory Multiple Myeloma
4
PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer
5




































